This content is not available in your region

AstraZeneca antibody cocktail works against Omicron in study

Access to the comments Comments
By Reuters
AstraZeneca antibody cocktail works against Omicron in study
AstraZeneca antibody cocktail works against Omicron in study   -   Copyright  Thomson Reuters 2021

– AstraZeneca said on Thursday a lab-study of its COVID-19 antibody cocktail, Evusheld, found that the treatment retained neutralising activity against the Omicron coronavirus variant, showing promise for wider use of the therapy.

The study was conducted by independent investigators of the U.S. Food and Drug Administration, the company said, adding that more analyses of Evusheld against Omicron are being conducted by AstraZeneca and third-parties, with data expected “very soon”.